In Conversation

"We truly held a groundbreaking technology in an emerging field where only “me-too” and “me-better” products were available in the international market."

Sergio Olivares, managing director at Olivares, explains the TPP’s impact on the Mexican pharmaceutical industry’s dynamism and Olivares’ business proposal as a one-stop shop solution to…

"Switzerland Innovation is to be an additional tool to further develop Switzerland’s innovative ecosystem, and keep our position as the most innovative country in the world."

"The mission for me and all my peers around the world is the same: be the main provider of innovative solutions for the challenges of the…

"We have leading universities, world-class research institutions, a highly-qualified workforce and unrivalled skills in the precision industry derived from a tradition of watchmaking."

From a product development perspective, as regulatory hurdles are constantly increasing, so is the price of the development: the average cost of developing a drug with…

"I am proud to confirm that the Mexican CRO industry now fully complies with the highest international quality standards."

"Since its conception, I have deeply believed that this novel EMT antagonist holds the potential to bring groundbreaking treatments to international patients"

"Both in terms of research and clinical care, we do not think in terms of single specialty areas. Instead we cover all biomedical areas."

"Cancer is not one disease; rather it is a collection of many different diseases that require specific diagnostic and therapeutic tools, specialized researchers and physicians."

"We need to understand medical and market needs and speak different languages (science, law and business) to interact effectively both with the scientific community and with…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here